)756(50)765(50)MODIFIED EBITDA(369)(939)(385)(1,104)TRANSGENOMIC, INC. AND SUBSIDIARYCONDENSED CONSOLIDATED BALANCE SHEETS(Dollars in thousands except per share data)June 30,2011December 31,(unaudited)2010ASSETSCURRENT ASSETS:Cash and cash equivalents
$
2,639$
3,454Accounts receivable
7,1947,601Inventories
3,3093,344Other current assets
860635Total current assets
14,00215,034PROPERTY AND EQUIPMENT, NET1,7711,602OTHER ASSETS:Goodwill
6,2756,275Intangibles
8,5228,962Other assets
130154$
30,700$
32,027LIABILITIES AND STOCKHOLDERS' EQUITYCURRENT LIABILITIES$9,905$8,253OTHER LIABILITIES:Long term debt less current maturities
7,4068,640Preferred stock conversion feature
7,6001,983Preferred Stock Warrant liability
3,0002,351Other long-term liabilities
1,008843Total liabilities
28,91922,070Redeemable Series A convertible preferred stock, $0.1 par value, 3,879,307 shares authorized, 2,586,205 shares issued and outstanding1,6701,457STOCKHOLDERS' EQUITY1118,500$
30,700$
32,027See notes to unaudited condensed consolidated financial statements.
'/>"/>
SOURCE Transgenomic, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related biology technology :1.
Transgenomic to Hold First Quarter Financial Results Conference Call on May 12, 20112.
Transgenomic, Inc. Enhances FAMILION® Genetic Test Offerings3.
Transgenomic, Inc. Presentations to Describe High-Sensitivity Detection of Cancer Biomarkers at the 2011 American Association for Cancer Research Meeting4.
Transgenomic Announces Discovery of a Novel Technique Which Enhances Analytic Sensitivity of Standard Sanger Sequencing to 1%5.
Reminder Webcast Alert: Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 20116.
Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 20117.
Transgenomic to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on February 178.
Transgenomic Reports Third Quarter Financial Results9.
Transgenomic Awarded $1,070,453 From U.S. Government Under the Patient Protection and Affordable Care Act10.
Transgenomic to Hold Third Quarter Financial Results Conference Call on November 15, 201011.
Transgenomic Develops New Assays to Detect EGFR Mutations Using COLD-PCR